Ken'ichi Ohno

Faculty of Pharmaceutical Sciences,Department of Pharmaceutical SciencesAssociate Professor
Graduate School of Pharmaceutical Sciences,Doctoral Program in Pharmaceutical SciencesAssociate Professor
Last Updated :2025/10/07

■Researcher basic information

Degree

  • Doctor (Pharmaceutical Science), Showa University

Field Of Study

  • Life sciences, Pharmaceuticals - analytical and physicochemistry
  • Nanotechnology/Materials, Analytical chemistry

■Career

Career

  • Apr. 2020 - Present
  • Apr. 2016 - Mar. 2020
  • Apr. 2015 - Mar. 2016
  • Apr. 2011 - Mar. 2015
  • Apr. 2009 - Mar. 2011
    Tokyo Medical and Dental University, Graduate School of Health Care Sciences
  • Apr. 2007 - Mar. 2011
    Showa University
  • Jul. 2004 - Mar. 2007
    Showa University
  • Apr. 2002 - Jun. 2004

Educational Background

  • Apr. 1999 - Mar. 2002, Showa University
  • Apr. 1997 - Mar. 1999, Showa University, Pharmaceutical Scientific Research Division
  • Apr. 1993 - Mar. 1997, Showa University, School of Pharmacy, Division of Pharmacology

Member History

  • 2011 - 2020
  • 2011 - 2016
  • 2014 - 2015
  • 2002 - 2011

■Research activity information

Paper

MISC

Lectures, oral presentations, etc.

  • キノリンカルボン酸試薬を用いたプロトン親和型誘導体化の開発とLC-ESI-MS/MSによるステロイドの定量               
    Mar. 2020
  • 電気化学測定によるセサモールの簡易分析法の開発               
    Mar. 2020
  • 白内障の病態形成に関与するクリスタリン中Asp残基異性化の乳酸による触媒機構 計算化学的・生化学的検討               
    Mar. 2019
  • 環境応答性蛍光リガンドの開発とエストロゲン様化合物の活性測定への応用               
    Mar. 2019
  • K562細胞におけるセサモールの抗腫瘍効果に関する構造活性               
    Sep. 2018
  • 環境応答性蛍光リガンドの開発とエストロゲン受容体に対する結合特性の評価               
    Mar. 2018
  • 環境応答性蛍光リガンドを用いたエストロゲン受容体結合アッセイの開発               
    Mar. 2017
  • 生物発光及び化学発光による硫化水素の高感度分析法の開発               
    Mar. 2017
  • チオウレア誘導体を用いた新規抗酸化能測定法の構築               
    Mar. 2017
  • 福祉教育の新たな広がりを模索して 理系学生に対する福祉教育の必要性に注目して 教員へのインタビューからの学び 仲間と一緒に課題解決               
    Sep. 2015
  • LC-ESI-MS/MS法による水酸化ステロイドのメタボローム解析 安定同位体標識カテコールエストロゲン-GSH付加体の調製               
    Mar. 2013
  • LC-ESI-MS/MS法による水酸化ステロイドのメタボローム解析 27ステロイドの一斉分析               
    Mar. 2012
  • 新規dATP誘導体を用いた生物発光によるSNP解析法               
    Oct. 2007
  • 合成女性ホルモンDiethylstilbestrolの化学発光計測               
    Aug. 2004
  • 蛍光偏光度測定による化学物質とエストロゲン受容体との相互作用解析               
    Mar. 2002
  • 新規チオール用発蛍光誘導体化試薬AcABD-Fの開発               
    Mar. 2002
  • 蛍光偏光度測定法による化学物質とエストロゲン受容体(ERβ)との相互作用解析               
    Mar. 2002
  • 蛍光偏光度測定による化学物質とエストロゲン受容体との相互作用解析(その2) 化学物質の受容体への親和性の評価               
    Mar. 2001

Research Themes

  • Targeted steroidomics research for diagnosis of adrenocortical disease
    Grant-in-Aid for Scientific Research (C)
    01 Apr. 2013 - 31 Mar. 2016
    It is essentially pre-requisite for the prompt diagnosis and the treatment of diseases caused by congenital adrenocortical hyper-/hypoplasia originated from the chromosomal abnormality, because those disease are usually intractable. In this research, our purpose was directed for the development of the microdetermination of cortisol and its related precursors/metabolites in small amount of biological samples based on the use of proton-affinitive derivatization and LC-ESI-MS/MS. In addition, we investigated the syntheses of deuterated internal standards, 18-oxocortisol as an authentic sample and the preparation method of various kinds of proton-affinitive derivatives, and their utilities in LC-ESI-MS/MS. Of these derivatives, we revealed that the picolinate ester was the most useful, and the application of the present derivative for the diagnosis of diseases of the abnormality of adrenocortical hormone production was carried out.
  • 前立腺がんの進展とアンドロゲンの動態解析               
    Apr. 2011 - Mar. 2012
  • Development of the analytical method for estrogen-o-quinones and its application to the study on the initiation mechanism of human breast cancer
    Grant-in-Aid for Scientific Research (C)
    Tohoku Pharmaceutical University
    2010 - 2012
    Selective and sensitive analytical method for estrogen-o-quinones derived from catechol estrogen with enzymatic or non-enzymatic manner was developed based on the use of phenazine derivatization and LC-MS. The present method enabled to determine the catalytic activity of protein and some metal ions on the process of oxidation of catechol estrogens to the corresponding o-quinones. Furthermore, analytical method for the glutathione and L-cysteine conjugates of these o-quinones was established as one of the model for determining protein adducts of o-quinones.
  • Development of ultrasensitive bioluminescent immunoassay by using DNA amplification technique
    Grant-in-Aid for Young Scientists (B)
    2009 - 2011
    In this study, a highly sensitive immunoassay was developed by using DNA amplification technique as detection system. Under isothermal condition, LAMP(Loop-mediated isothermal Amplification) and RCA(Rolling Circle Amplification) reaction enable successive DNA amplification. In order to apply DNA amplification to the detection system on immunoassay, DNA-conjugated antigen was prepared for competitive immunoassay. As a result, physically and chemically stable DNA provided highly efficient and sensitive signal amplification based on genetic engineering.
  • Production of aptamer by SELEX technique and its application to diagnosis
    Grant-in-Aid for Scientific Research (C)
    Showa University
    2007 - 2009
    Aptamers are nucleic acid ligands that recognize a wide range of target molecules with high affinity and specificity. They are generated by in vitro selection of a randomized oligonucleotide pool in a technique known as systematic evolution of ligands by exponential enrichment (SELEX). The development of in vitro selection and amplification technology has allowed the identification of specific aptamers that bind target molecules with high affinity and even discriminate between closely related targets. Their binding affinities are comparable to those of antibodies and antigens. In comparison to antibodies, aptamers have the advantages of (i) simple preparation by chemical or enzymatic synthesis, (ii) thermal stability, (iii) discrimination of structural differences, (iv) ease of surface attachment for analysis, (v) ease of binding property modification through minor changes in sequence, (vi) minimization of experimental animal usage, and (viii) preparation for targets that are toxic or not inherently immunogenic. Aptamers are suitable as analytical, diagnostic, and therapeutic tools in applications requiring molecular recognition and are consequently gaining increased attention for their potential uses. In this study, to develop new diagnosis method, we developed sensitive and high performance aptamer binding assay using microchip electorophoresis, and prepared new aptamers for HMG (human menopausal gonadotropin), amyloid-β peptide and oxytocin. At first, a assay for Thronbin was developed using thrombin aptamer and microchip electrophoresis method, the result showed detection limit of 1 pmol. Next we prepared aptamer for HMG by SELEX, and HMG was detected by using the aptamer in a similar manner. In addition, amyloid-β peptide and oxytocin aptmaers were prepared.

■University education and qualification information

Qualifications, licenses

  • 30 May 1997
    Pharmacist License
  • 08 Apr. 2004
    Class A Hazardous Materials Engneer's License